Active	Status	Sponsor type	Region	Phase	Filter
11 Active 2 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « February » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 2   - « February » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 2   Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brinton, Roberta Diaz
REGEN-BRAIN©, NCT04838301: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Recruiting	2	200	US	Allopregnanolone, Allo, Placebo	University of Arizona, National Institute on Aging (NIA), Syneos Health, University of Southern California, ADM Diagnostics	Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases	04/25	12/26
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27
Allo-IM, NCT03748303: Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study	Active, not recruiting	1	12	US	Allopregnanolone, Allo	University of Arizona, University of Southern California, Alzheimer's Association	Alzheimer Dementia	12/22	06/23
Allo-PD, NCT06263010: Allopregnanolone As a Regenerative Treatment for Parkinson's Disease	Active, not recruiting	1	10	US	Allopregnanolone	Roberta Brinton	Parkinson Disease	05/25	05/25
Mosconi, Lisa
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27
CEDAR, NCT03687710: The Comparative Effectiveness Dementia & Alzheimer's Registry	Active, not recruiting	N/A	452	US	Multidomain precision medicine intervention	Weill Medical College of Cornell University	Alzheimer Disease, Mild Cognitive Impairment	06/26	06/26
Hernandez, Gerson D
HF-Relief, NCT06186531: PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health	Recruiting	2	132	US	PhytoSERM, Placebo	NeuTherapeutics, University of Arizona	Menopause, Hot Flashes	11/24	11/24
REGEN-BRAIN©, NCT04838301: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Recruiting	2	200	US	Allopregnanolone, Allo, Placebo	University of Arizona, National Institute on Aging (NIA), Syneos Health, University of Southern California, ADM Diagnostics	Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases	04/25	12/26
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27
Allo-PD, NCT06263010: Allopregnanolone As a Regenerative Treatment for Parkinson's Disease	Active, not recruiting	1	10	US	Allopregnanolone	Roberta Brinton	Parkinson Disease	05/25	05/25
Williams, Schantel
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brinton, Roberta Diaz
REGEN-BRAIN©, NCT04838301: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Recruiting	2	200	US	Allopregnanolone, Allo, Placebo	University of Arizona, National Institute on Aging (NIA), Syneos Health, University of Southern California, ADM Diagnostics	Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases	04/25	12/26
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27
Allo-IM, NCT03748303: Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study	Active, not recruiting	1	12	US	Allopregnanolone, Allo	University of Arizona, University of Southern California, Alzheimer's Association	Alzheimer Dementia	12/22	06/23
Allo-PD, NCT06263010: Allopregnanolone As a Regenerative Treatment for Parkinson's Disease	Active, not recruiting	1	10	US	Allopregnanolone	Roberta Brinton	Parkinson Disease	05/25	05/25
Mosconi, Lisa
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27
CEDAR, NCT03687710: The Comparative Effectiveness Dementia & Alzheimer's Registry	Active, not recruiting	N/A	452	US	Multidomain precision medicine intervention	Weill Medical College of Cornell University	Alzheimer Disease, Mild Cognitive Impairment	06/26	06/26
Hernandez, Gerson D
HF-Relief, NCT06186531: PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health	Recruiting	2	132	US	PhytoSERM, Placebo	NeuTherapeutics, University of Arizona	Menopause, Hot Flashes	11/24	11/24
REGEN-BRAIN©, NCT04838301: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Recruiting	2	200	US	Allopregnanolone, Allo, Placebo	University of Arizona, National Institute on Aging (NIA), Syneos Health, University of Southern California, ADM Diagnostics	Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases	04/25	12/26
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27
Allo-PD, NCT06263010: Allopregnanolone As a Regenerative Treatment for Parkinson's Disease	Active, not recruiting	1	10	US	Allopregnanolone	Roberta Brinton	Parkinson Disease	05/25	05/25
Williams, Schantel
Phyto-2022-01, NCT05664477: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition	Recruiting	2	100	US	PhytoSERM, Placebo	Roberta Brinton, National Institute on Aging (NIA), Cornell University, ADM Diagnostics	Menopause, Cognitive Change, Brain Disorder, Metabolic	01/27	01/27